Works matching IS 15307905 AND DT 2025 AND VI 25 AND IP 2
Results: 10
Dihydromyricetin Protects Against Hypoxia/Reoxygenation Injury in Cardiomyocytes by Activating miR-34a-Mediated Notch1 Pathway.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 294, doi. 10.1007/s12012-025-09959-5
- By:
- Publication type:
- Article
Cardiotoxicity Associated With a Low Doses of 5-FU Promotes Morphoquantitative Changes in the Intrinsic Cardiac Nervous System.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 193, doi. 10.1007/s12012-024-09958-y
- By:
- Publication type:
- Article
Associations Between Lead and Cadmium Exposure and Subclinical Cardiovascular Disease in U.S. Adults.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 282, doi. 10.1007/s12012-024-09955-1
- By:
- Publication type:
- Article
Unraveling Cardiovascular Risks and Benefits of COVID-19 Vaccines: A Systematic Review.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 306, doi. 10.1007/s12012-024-09954-2
- By:
- Publication type:
- Article
Astemizole Exacerbates 5-Fluorouracil-Triggered Cardiotoxicity by Enhancing Ptgs2.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 205, doi. 10.1007/s12012-024-09953-3
- By:
- Publication type:
- Article
Doxorubicin or Epirubicin Versus Liposomal Doxorubicin Therapy—Differences in Cardiotoxicity.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 248, doi. 10.1007/s12012-024-09952-4
- By:
- Publication type:
- Article
Thiolutin Alleviates Cardiotoxic Effects of Doxorubicin by Suppressing NLRP3 Inflammasome in the Mouse Model.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 182, doi. 10.1007/s12012-024-09947-1
- By:
- Publication type:
- Article
Small Molecules Targeting Mitochondria: A Mechanistic Approach to Combating Doxorubicin-Induced Cardiotoxicity.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 216, doi. 10.1007/s12012-024-09941-7
- By:
- Publication type:
- Article
The Protective Effects of Carvacrol Against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 167, doi. 10.1007/s12012-024-09940-8
- By:
- Publication type:
- Article
A Meta-analysis of the Risk of Adverse Cardiovascular Events in Patients with Cancer Treated with Inhibitors of the PI3K/AKT/mTOR Signaling Pathway.
- Published in:
- Cardiovascular Toxicology, 2025, v. 25, n. 2, p. 269, doi. 10.1007/s12012-024-09933-7
- By:
- Publication type:
- Article